REPORTS

Let’s Pullulate and Expand Your Business

Global Antibiotic Resistance Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Jul 14, 2020  |  162 PAGES  |  REPORT CODE: CMM369260
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Hence, antibiotic resistance leads to higher medical costs and increased mortality.

The Antibiotic Resistance is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period. The research provides insights for the global Antibiotic Resistance market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Antibiotic Resistance industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Antibiotic Resistance Market Segmentations:

By Players:

  • Allergan

  • AmpliPhi Biosciences

  • BioVersys GmbH

  • Macrolide Pharmaceuticals

  • Melinta Therapeutics

  • Merck

  • Nabriva Therapeutics

  • Nemesis Bioscience

  • Tetraphase Pharmaceuticals

  • The Medicines Company

  • TPfizer

  • Westway Health

By Types:

  • Urinary Tract Infection

  • Intra-Abdominal Infections

  • Blood Stream Infections

  • Clostridium Difficile Infections

  • Acute Bacterial Skin and Skin Structure Infections

  • Bacterial Pneumonia

By End-User:

  • Oxazolidinones

  • Lipoglycopeptides

  • Tetracyclines

  • Cephalosporins

  • Combination therapies

  • Other

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Antibiotic Resistance Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Antibiotic Resistance Market Size and Growth Rate of Urinary Tract Infection from 2014 to 2026

    • 1.3.2 Global Antibiotic Resistance Market Size and Growth Rate of Intra-Abdominal Infections from 2014 to 2026

    • 1.3.3 Global Antibiotic Resistance Market Size and Growth Rate of Blood Stream Infections from 2014 to 2026

    • 1.3.4 Global Antibiotic Resistance Market Size and Growth Rate of Clostridium Difficile Infections from 2014 to 2026

    • 1.3.5 Global Antibiotic Resistance Market Size and Growth Rate of Acute Bacterial Skin and Skin Structure Infections from 2014 to 2026

    • 1.3.6 Global Antibiotic Resistance Market Size and Growth Rate of Bacterial Pneumonia from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Antibiotic Resistance Market Size and Growth Rate of Oxazolidinones from 2014 to 2026

    • 1.4.2 Global Antibiotic Resistance Market Size and Growth Rate of Lipoglycopeptides from 2014 to 2026

    • 1.4.3 Global Antibiotic Resistance Market Size and Growth Rate of Tetracyclines from 2014 to 2026

    • 1.4.4 Global Antibiotic Resistance Market Size and Growth Rate of Cephalosporins from 2014 to 2026

    • 1.4.5 Global Antibiotic Resistance Market Size and Growth Rate of Combination therapies from 2014 to 2026

    • 1.4.6 Global Antibiotic Resistance Market Size and Growth Rate of Other from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Antibiotic Resistance Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Antibiotic Resistance Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Antibiotic Resistance by Major Types

    • 3.4.1 Antibiotic Resistance Market Size and Growth Rate of Urinary Tract Infection

    • 3.4.2 Antibiotic Resistance Market Size and Growth Rate of Intra-Abdominal Infections

    • 3.4.3 Antibiotic Resistance Market Size and Growth Rate of Blood Stream Infections

    • 3.4.4 Antibiotic Resistance Market Size and Growth Rate of Clostridium Difficile Infections

    • 3.4.5 Antibiotic Resistance Market Size and Growth Rate of Acute Bacterial Skin and Skin Structure Infections

    • 3.4.6 Antibiotic Resistance Market Size and Growth Rate of Bacterial Pneumonia

4 Segmentation of Antibiotic Resistance Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Antibiotic Resistance by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Antibiotic Resistance in Oxazolidinones

    • 4.4.2 Market Size and Growth Rate of Antibiotic Resistance in Lipoglycopeptides

    • 4.4.3 Market Size and Growth Rate of Antibiotic Resistance in Tetracyclines

    • 4.4.4 Market Size and Growth Rate of Antibiotic Resistance in Cephalosporins

    • 4.4.5 Market Size and Growth Rate of Antibiotic Resistance in Combination therapies

    • 4.4.6 Market Size and Growth Rate of Antibiotic Resistance in Other

5 Market Analysis by Major Regions

  • 5.1 Global Antibiotic Resistance Production Analysis by Major Regions

  • 5.2 Global Antibiotic Resistance Consumption Analysis by Major Regions

  • 5.3 Global Antibiotic Resistance Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Antibiotic Resistance Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Antibiotic Resistance Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Antibiotic Resistance Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Antibiotic Resistance Production, Import, Consumption and Export Analysis

6 Product Commodity of Antibiotic Resistance Market in Major Countries

  • 6.1 Top 5 Export Countries in Antibiotic Resistance market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Antibiotic Resistance market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Antibiotic Resistance market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Antibiotic Resistance market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Antibiotic Resistance market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Antibiotic Resistance market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Antibiotic Resistance Landscape Analysis

  • 7.1 North America Antibiotic Resistance Landscape Analysis by Major Types

  • 7.2 North America Antibiotic Resistance Landscape Analysis by Major End-Users

  • 7.3 North America Antibiotic Resistance Landscape Analysis by Major Countries

    • 7.3.1 United States Antibiotic Resistance Market Volume and Growth Rate

    • 7.3.2 Canada Antibiotic Resistance Market Volume and Growth Rate

    • 7.3.3 Mexico Antibiotic Resistance Market Volume and Growth Rate

8 Europe Antibiotic Resistance Landscape Analysis

  • 8.1 Europe Antibiotic Resistance Landscape Analysis by Major Types

  • 8.2 Europe Antibiotic Resistance Landscape Analysis by Major End-Users

  • 8.3 Europe Antibiotic Resistance Landscape Analysis by Major Countries

    • 8.3.1 Germany Antibiotic Resistance Market Volume and Growth Rate

    • 8.3.2 UK Antibiotic Resistance Market Volume and Growth Rate

    • 8.3.3 France Antibiotic Resistance Market Volume and Growth Rate

    • 8.3.4 Italy Antibiotic Resistance Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Antibiotic Resistance Market Volume and Growth Rate

    • 8.3.6 Spain Antibiotic Resistance Market Volume and Growth Rate

    • 8.3.7 Belgium Antibiotic Resistance Market Volume and Growth Rate

    • 8.3.8 Poland Antibiotic Resistance Market Volume and Growth Rate

    • 8.3.9 Russia Antibiotic Resistance Market Volume and Growth Rate

    • 8.3.10 Turkey Antibiotic Resistance Market Volume and Growth Rate

9 Asia Pacific Antibiotic Resistance Landscape Analysis

  • 9.1 Asia Pacific Antibiotic Resistance Landscape Analysis by Major Types

  • 9.2 Asia Pacific Antibiotic Resistance Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Antibiotic Resistance Landscape Analysis by Major Countries

    • 9.3.1 China Antibiotic Resistance Market Volume and Growth Rate

    • 9.3.2 Japan Antibiotic Resistance Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Antibiotic Resistance Market Volume and Growth Rate

    • 9.3.4 India Antibiotic Resistance Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Antibiotic Resistance Market Volume and Growth Rate

    • 9.3.6 South Korea Antibiotic Resistance Market Volume and Growth Rate

10 Latin America, Middle East & Africa Antibiotic Resistance Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Antibiotic Resistance Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Antibiotic Resistance Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Antibiotic Resistance Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Antibiotic Resistance Market Volume and Growth Rate

    • 10.3.2 Brazil Antibiotic Resistance Market Volume and Growth Rate

    • 10.3.3 Nigeria Antibiotic Resistance Market Volume and Growth Rate

    • 10.3.4 South Africa Antibiotic Resistance Market Volume and Growth Rate 

    • 10.3.5 Argentina Antibiotic Resistance Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Allergan

    • 11.1.1 Allergan Company Profile and Recent Development

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 AmpliPhi Biosciences

    • 11.2.1 AmpliPhi Biosciences Company Profile and Recent Development

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 BioVersys GmbH

    • 11.3.1 BioVersys GmbH Company Profile and Recent Development

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Macrolide Pharmaceuticals

    • 11.4.1 Macrolide Pharmaceuticals Company Profile and Recent Development

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Melinta Therapeutics

    • 11.5.1 Melinta Therapeutics Company Profile and Recent Development

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Merck

    • 11.6.1 Merck Company Profile and Recent Development

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 Nabriva Therapeutics

    • 11.7.1 Nabriva Therapeutics Company Profile and Recent Development

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Nemesis Bioscience

    • 11.8.1 Nemesis Bioscience Company Profile and Recent Development

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 Tetraphase Pharmaceuticals

    • 11.9.1 Tetraphase Pharmaceuticals Company Profile and Recent Development

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 The Medicines Company

    • 11.10.1 The Medicines Company Company Profile and Recent Development

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 TPfizer

    • 11.11.1 TPfizer Company Profile and Recent Development

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Westway Health

    • 11.12.1 Westway Health Company Profile and Recent Development

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 118 Figures and 179 Tables)

  • Figure Product Picture

  • Figure Antibiotic Resistance Market Size and Growth Rate of Urinary Tract Infection from 2014 to 2026

  • Figure Antibiotic Resistance Market Size and Growth Rate of Intra-Abdominal Infections from 2014 to 2026

  • Figure Antibiotic Resistance Market Size and Growth Rate of Blood Stream Infections from 2014 to 2026

  • Figure Antibiotic Resistance Market Size and Growth Rate of Clostridium Difficile Infections from 2014 to 2026

  • Figure Antibiotic Resistance Market Size and Growth Rate of Acute Bacterial Skin and Skin Structure Infections from 2014 to 2026

  • Figure Antibiotic Resistance Market Size and Growth Rate of Bacterial Pneumonia from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Antibiotic Resistance Market Size and Growth Rate of Oxazolidinones from 2014 to 2026

  • Figure Global Antibiotic Resistance Market Size and Growth Rate of Lipoglycopeptides from 2014 to 2026

  • Figure Global Antibiotic Resistance Market Size and Growth Rate of Tetracyclines from 2014 to 2026

  • Figure Global Antibiotic Resistance Market Size and Growth Rate of Cephalosporins from 2014 to 2026

  • Figure Global Antibiotic Resistance Market Size and Growth Rate of Combination therapies from 2014 to 2026

  • Figure Global Antibiotic Resistance Market Size and Growth Rate of Other from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Antibiotic Resistance Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Antibiotic Resistance Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Antibiotic Resistance

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Antibiotic Resistance by Different Types from 2014 to 2026

  • Table Consumption Share of Antibiotic Resistance by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Urinary Tract Infection

  • Figure Market Size and Growth Rate of Intra-Abdominal Infections

  • Figure Market Size and Growth Rate of Blood Stream Infections

  • Figure Market Size and Growth Rate of Clostridium Difficile Infections

  • Figure Market Size and Growth Rate of Acute Bacterial Skin and Skin Structure Infections

  • Figure Market Size and Growth Rate of Bacterial Pneumonia

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Antibiotic Resistance by Different End-Users from 2014 to 2026

  • Table Consumption Share of Antibiotic Resistance by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Oxazolidinones

  • Figure Market Size and Growth Rate of Lipoglycopeptides

  • Figure Market Size and Growth Rate of Tetracyclines

  • Figure Market Size and Growth Rate of Cephalosporins

  • Figure Market Size and Growth Rate of Combination therapies

  • Figure Market Size and Growth Rate of Other

  • Table Global Antibiotic Resistance Production by Major Regions

  • Table Global Antibiotic Resistance Production Share by Major Regions

  • Figure Global Antibiotic Resistance Production Share by Major Regions in 2014

  • Figure Global Antibiotic Resistance Production Share by Major Regions in 2018

  • Figure Global Antibiotic Resistance Production Share by Major Regions in 2026

  • Table Global Antibiotic Resistance Consumption by Major Regions

  • Table Global Antibiotic Resistance Consumption Share by Major Regions

  • Figure Global Antibiotic Resistance Consumption Share by Major Regions in 2014

  • Figure Global Antibiotic Resistance Consumption Share by Major Regions in 2018

  • Figure Global Antibiotic Resistance Consumption Share by Major Regions in 2026

  • Table North America Antibiotic Resistance Production, Import, Consumption and Export Analysis

  • Table Europe Antibiotic Resistance Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Antibiotic Resistance Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Antibiotic Resistance Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Antibiotic Resistance market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Antibiotic Resistance market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Antibiotic Resistance market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Antibiotic Resistance market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Antibiotic Resistance Consumption by Types from 2014 to 2026

  • Table North America Antibiotic Resistance Consumption Share by Types from 2014 to 2026

  • Figure North America Antibiotic Resistance Consumption Share by Types in 2014

  • Figure North America Antibiotic Resistance Consumption Share by Types in 2018

  • Figure North America Antibiotic Resistance Consumption Share by Types in 2026

  • Table North America Antibiotic Resistance Consumption by End-Users from 2014 to 2026

  • Table North America Antibiotic Resistance Consumption Share by End-Users from 2014 to 2026

  • Figure North America Antibiotic Resistance Consumption Share by End-Users in 2014

  • Figure North America Antibiotic Resistance Consumption Share by End-Users in 2018

  • Figure North America Antibiotic Resistance Consumption Share by End-Users in 2026

  • Table North America Antibiotic Resistance Consumption by Major Countries from 2014 to 2026

  • Table North America Antibiotic Resistance Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Antibiotic Resistance Consumption Share by Major Countries in 2014

  • Figure North America Antibiotic Resistance Consumption Share by Major Countries in 2018

  • Figure North America Antibiotic Resistance Consumption Share by Major Countries in 2026

  • Figure United States Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Antibiotic Resistance Consumption by Types from 2014 to 2026

  • Table Europe Antibiotic Resistance Consumption Share by Types from 2014 to 2026

  • Figure Europe Antibiotic Resistance Consumption Share by Types in 2014

  • Figure Europe Antibiotic Resistance Consumption Share by Types in 2018

  • Figure Europe Antibiotic Resistance Consumption Share by Types in 2026

  • Table Europe Antibiotic Resistance Consumption by End-Users from 2014 to 2026

  • Table Europe Antibiotic Resistance Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Antibiotic Resistance Consumption Share by End-Users in 2014

  • Figure Europe Antibiotic Resistance Consumption Share by End-Users in 2018

  • Figure Europe Antibiotic Resistance Consumption Share by End-Users in 2026

  • Table Europe Antibiotic Resistance Consumption by Major Countries from 2014 to 2026

  • Table Europe Antibiotic Resistance Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Antibiotic Resistance Consumption Share by Major Countries in 2014

  • Figure Europe Antibiotic Resistance Consumption Share by Major Countries in 2018

  • Figure Europe Antibiotic Resistance Consumption Share by Major Countries in 2026

  • Figure Germany Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure France Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Antibiotic Resistance Consumption by Types from 2014 to 2026

  • Table Asia Pacific Antibiotic Resistance Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Antibiotic Resistance Consumption Share by Types in 2014

  • Figure Asia Pacific Antibiotic Resistance Consumption Share by Types in 2018

  • Figure Asia Pacific Antibiotic Resistance Consumption Share by Types in 2026

  • Table Asia Pacific Antibiotic Resistance Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Antibiotic Resistance Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Antibiotic Resistance Consumption Share by End-Users in 2014

  • Figure Asia Pacific Antibiotic Resistance Consumption Share by End-Users in 2018

  • Figure Asia Pacific Antibiotic Resistance Consumption Share by End-Users in 2026

  • Table Asia Pacific Antibiotic Resistance Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Antibiotic Resistance Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Antibiotic Resistance Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Antibiotic Resistance Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Antibiotic Resistance Consumption Share by Major Countries in 2026

  • Figure China Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandAntibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure India Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Antibiotic Resistance Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Antibiotic Resistance Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Antibiotic Resistance Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Antibiotic Resistance Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Antibiotic Resistance Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Antibiotic Resistance Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Antibiotic Resistance Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Antibiotic Resistance Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Antibiotic Resistance Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Antibiotic Resistance Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Antibiotic Resistance Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Antibiotic Resistance Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Antibiotic Resistance Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Antibiotic Resistance Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Antibiotic Resistance Consumption Share by Major Countries in 2026

  • Figure GCC Countries Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Antibiotic Resistance Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Allergan

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

  • Figure Sales and Growth Rate Analysis of Allergan

  • Figure Revenue and Market Share Analysis of Allergan

  • Table Product and Service Introduction of Allergan

  • Table Company Profile and Development Status of AmpliPhi Biosciences

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AmpliPhi Biosciences

  • Figure Sales and Growth Rate Analysis of AmpliPhi Biosciences

  • Figure Revenue and Market Share Analysis of AmpliPhi Biosciences

  • Table Product and Service Introduction of AmpliPhi Biosciences

  • Table Company Profile and Development Status of BioVersys GmbH

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioVersys GmbH

  • Figure Sales and Growth Rate Analysis of BioVersys GmbH

  • Figure Revenue and Market Share Analysis of BioVersys GmbH

  • Table Product and Service Introduction of BioVersys GmbH

  • Table Company Profile and Development Status of Macrolide Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Macrolide Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Macrolide Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Macrolide Pharmaceuticals

  • Table Product and Service Introduction of Macrolide Pharmaceuticals

  • Table Company Profile and Development Status of Melinta Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Melinta Therapeutics

  • Figure Sales and Growth Rate Analysis of Melinta Therapeutics

  • Figure Revenue and Market Share Analysis of Melinta Therapeutics

  • Table Product and Service Introduction of Melinta Therapeutics

  • Table Company Profile and Development Status of Merck

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

  • Figure Sales and Growth Rate Analysis of Merck

  • Figure Revenue and Market Share Analysis of Merck

  • Table Product and Service Introduction of Merck

  • Table Company Profile and Development Status of Nabriva Therapeutics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nabriva Therapeutics

  • Figure Sales and Growth Rate Analysis of Nabriva Therapeutics

  • Figure Revenue and Market Share Analysis of Nabriva Therapeutics

  • Table Product and Service Introduction of Nabriva Therapeutics

  • Table Company Profile and Development Status of Nemesis Bioscience

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nemesis Bioscience

  • Figure Sales and Growth Rate Analysis of Nemesis Bioscience

  • Figure Revenue and Market Share Analysis of Nemesis Bioscience

  • Table Product and Service Introduction of Nemesis Bioscience

  • Table Company Profile and Development Status of Tetraphase Pharmaceuticals

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tetraphase Pharmaceuticals

  • Figure Sales and Growth Rate Analysis of Tetraphase Pharmaceuticals

  • Figure Revenue and Market Share Analysis of Tetraphase Pharmaceuticals

  • Table Product and Service Introduction of Tetraphase Pharmaceuticals

  • Table Company Profile and Development Status of The Medicines Company

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of The Medicines Company

  • Figure Sales and Growth Rate Analysis of The Medicines Company

  • Figure Revenue and Market Share Analysis of The Medicines Company

  • Table Product and Service Introduction of The Medicines Company

  • Table Company Profile and Development Status of TPfizer

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of TPfizer

  • Figure Sales and Growth Rate Analysis of TPfizer

  • Figure Revenue and Market Share Analysis of TPfizer

  • Table Product and Service Introduction of TPfizer

  • Table Company Profile and Development Status of Westway Health

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Westway Health

  • Figure Sales and Growth Rate Analysis of Westway Health

  • Figure Revenue and Market Share Analysis of Westway Health

  • Table Product and Service Introduction of Westway Health


Report Purchase

reports
$4480
$8960
BUY NOWClick MeBUY NOW
top